Explore educational content from VCCC Alliance lectures, symposia and conferences to be informed of the latest developments.
Monday 26 July 2021
Monday Lunch Live with Professor Desmond Yip, Clinical Director, Department of Medical Oncology at The Canberra Hospital and Dr Andrew Soma, Oncology Registrar, National Referral Hospital, Honiara and VCCC Master of Cancer Sciences student.
This presentation outlines the work of Professor Desmond Yip and a team from The Canberra Hospital in scoping cancer services, providing initial equipment, mentoring, training and upskilling medical, nursing and pharmacy staff to support and develop this unit to provide cancer care to the people of this island nation.
Dr Andrew Soma is on the ground at the National Referral Hospital working to establish Solomon Island's first oncology unit.
Wednesday 21 July 2021
Breast Cancer Education Series with Dr Belinda Yeo.
Presenting a patient case at a multidisciplinary meeting (MDM) is a standard procedure in a new diagnosis. Often controversial discussions arise with differing treatment approaches. This is common in complex cases where the cancer type, extent or order of treatment is not clear..
VCCC Research & Education Leads, Dr Belinda Yeo and Professor Bruce Mann, and a multidisciplinary panel of experts who navigate participants through real life case presentations of tricky cases in breast cancer.
Monday 19 July 2021
Monday Lunch Live with Professor Gail Garvey, Menzies School of Health, John Willis, Group Manager Inclusive Health at St Vincent's Health and Darlene Dreise, Torres Strait Islander woman and Chair of the Reconciliation Action Plan Steering Committee for St Vincent’s Health Australia.
The trio discuss the importance of improving cancer care for Aboriginal and Torres Strait Islander people followed by live Q&A discussion.
Every day around five Aboriginal and Torres Strait Islander people are diagnosed with cancer. Indigenous Australians have a slightly higher rate of cancer diagnosis and are approximately 40 per cent more likely to die from cancer than non-Indigenous Australians.
Wednesday 14 July 2021
Breast Cancer Grand Round with Professor Robin Anderson.
Hear from the Head of the Translational Breast Cancer Program at Olivia Newton-John Cancer Research Institute who will present studies aimed at understanding how the BMP4 gene acts to suppress metastasis in breast cancer.
Professor Anderson presents her recent studies that are aimed at developing new therapies that activate the same signalling pathways as BMP4. Her research identifies genes that regulate the process of metastasis and develop new therapies that can effectively control metastatic disease.
Monday 12 July 2021
Monday Lunch Live with Professor Simon Harrison, Associate Professor Dominic Wall and Dr Gretchen Poortinga.
Hear from the team at the Centre of Excellence in Cellular Immunotherapy who will provide an update on the current program of activities including the rollout of a unique rapid pilot clinical trial program for CAR-T and other novel cellular immunotherapies.
The Centre of Excellence in Cellular Immunotherapy (CoE CIT) was developed to deliver globally competitive breakthroughs in chimeric antigen receptor T-cell therapies (CAR-T) and other cell-based immunotherapies for cancer. In doing so, it facilitates early and affordable access to practice-changing therapies in Australia and the wider Asia-Pacific region.
Monday 5 July 2021
Monday Lunch Live with Professor Jill Francis and Associate Professor Niall Corcoran.
Delivery of low-value care is a problem across all health systems. The body of knowledge in implementation science includes methods and frameworks for investigating and addressing this problem.
Together Jill and Niall present examples of implementation science frameworks and how their application is exemplified through the challenges associated with the de-escalation of prostate cancer therapies. These methods are transferable to addressing low-value care in other clinical contexts.
Wednesday 30 June 2021
Breast Cancer Grand Round with Dr Alexandra Murphy.
Hear from Dr Murphy, a Cardiologist at Austin Hospital in the Cardio-Hematology Clinic where she manages patients with cardiac issues who have cancer
Heart disease and cancer are the two leading causes of death in the developed world. There are numerous common risk factors, and many patients are living with both conditions. Due to advancements in modern cancer therapy, we are now seeing higher rates of survival and the conversion of terminal illness into chronic disease. As a result, cardiovascular disease has become a leading cause of death in cancer survivors.
Tuesday 29 June 2021
Brain Cancer seminar with presenter Professor David Ashley, Director Brain Cancer Centre, Duke University
Monday 21 June 2021
Monday Lunch Live with Associate Professor Ian Collins, South West Health Care Oncology, Associate Professor Kate Burbury, Peter MacCallum Cancer Centre, Dr Craig Underhill, Albury Wodonga Regional Cancer Centre, Anne Woollett, Alfred Trial Hub, Alfred Health.
Patients living with cancer in regional and rural Victoria can experience disadvantage including lower survival rates and barriers to clinical trial access compared to patients living in Melbourne.
Recent increased funding, focus and effective collaborations are generating more cancer clinical trials in regional Victoria. Innovations in teletrials and telehealth are contributing to greater localised opportunities. The win? Improved health outcomes for regional Victorians.
For a panel discussion, presenters are joined by panellists Donna Long, Regional Trials Network Manager, Kathleen Wilkins, Regional Consumer Expert, and Dr Dayna Swiatek, Victorian Cancer Agency, Department of Health.
Wednesday 16 June 2021
Breast Cancer Grand Round with Associate Professor Farshad Foroudi.
Hear from the Director of Radiation Oncology at Austin Hospital who will provide an overview of the new state-wide MR Linear Accelerator, with a focus on breast cancer indications and trials.
Associate Professor Foroudi has extensive experience in technical and translational radiation oncology trials and is the immediate past President of the Trans Tasman Radiation Oncology Group (TROG). He is also a previous chair of the TROG scientific committee.
Associate Professor Foroudi is currently the chair of the MR in Radiotherapy working group for TROG and member of the Uro-oncology and Breast cancer subcommittee committees. TROG is one of the largest collaborative cancer trials groups in Australasia. Associate Professor Foroudi has been instrumental in the development of the Austin Health State MRI Linear Accelerator based at the Olivia Newton John Cancer Centre.
Tuesday 15 June 2021
Head and Neck Cancer Symposium Facilitated by Professor David Wiesenfield, VCCC Research and Education Lean and presented by Professor Clare Delany, Professor of Ethics at the University of Melbourne.
Multidisciplinary experts discuss the fundamental decisions regarding risk, burden and benefits of treatment that require a patient centred approach. Panel discussion addresses questions including:
Thursday 22 July 2021
Consumers, carers, clinicians, and researchers were invited to join a meaningful discussion contributing to providing those affected by brain cancer a ‘toolkit’ for self-care, responsive to the challenges of living with a brain cancer diagnosis.
Professor Kate Drummond, Director of Neurosurgery at The Royal Melbourne Hospital, is joined by a multidisciplinary panel of experts who provide an overview of the proposed care platform which intends to improve geographic, physical, cognitive, and social care barriers for brain cancer survivors, whilst extending the in-hospital therapeutic relationship into patients’ and carers’ homes and communities.
Survivorship post-treatment – a patient’s perspective
Lucas Adda, Cooperative Trials Group for Neuro-Oncology (COGNO) consumer advisory panel member
Working together for a successful outcome - what needs to be done to support service implementation?
Professor Wendy Chapman, Director Centre for Digital Transformation of Health, University of Melbourne
The impact of a supportive care digital resource on the health care system
Professor Mei Krishnasamy, Director, Academic Nursing Unit Peter MacCallum Cancer Centre
Research-based digital innovation in healthcare can work effectively
Evan Davey, Partner, Two Bulls
Monday 7 June 2021
Monday Lunch Live with Dr Sue Haupt, Peter MacCallum Cancer Centre, and Todd Harper, CEO Cancer Council Victoria.
Evidence shows that the differences in cancer diagnoses between the sexes cannot be entirely explained by lifestyle and hormonal differences. The increased mortality rates of many cancer types are two times higher in males than females, however the current standard of care does not differentiate on patient sex in non-reproductive cancers.
Dr Sue Haupt will provide an overview of the risks associated with failing to consider sex in basic cancer research. This awareness has stemmed from her research into core pathways of tumour suppression that differ between the sexes.
Wednesday 2 June 2021
Grand Round Breast Cancer with Professor Bruce Mann, VCCC Research & Education Lead and breast cancer surgeon.
Radiation therapy after breast-conserving surgery for ductal carcinoma in situ (DCIS) is known to reduce the risk for ipsilateral breast events without altering survival. Its use varies widely due to differing assessments of risk-benefit ratio. Precise assessment of postsurgical radiation therapy benefit would allow individualised treatment decisions.
DCISionRT is a new assay that may allow this assessment. Professor Bruce Mann will provide an overview of the management of DCIS, work done locally to validate the DCISionRT assay and outline plans for the future assessment of the assay.
Wednesday 26 May 2021
Breast Cancer Education Series with Dr Belinda Yeo.
Treatment for oligometastatic and advanced disease have improved substantially over the past decade. Molecular subtyping, improved stage imaging and the role of liquid biopsy have led to an increase in the detection of small volume metastases.
In this webinar Dr Belinda Yeo and a multidisciplinary panel of experts discuss emerging data, aggressive treatment options and the impact on patient quality of life. The panel explore the differences in oligometastatic treatment and metastatic treatment options with audience participation in discussion.
Wednesday 19 May 2021
Breast Cancer Grand Round with Associate Professor Peter Simpson and Dr Belinda Yeo.
ILC is the most commonly diagnosed histological type of breast cancer. Tumours have a characteristic dis-cohesive and invasive growth pattern that is underpinned by mutational inactivation of the CDH1 (E-cadherin) gene.
Associate Professor Peter Simpson, University of Queensland, presents an overview of ICL of the breast. Peter reviews how some tumours are histological grade two and oestrogen receptor positive, and how there are a diverse series of morphological and molecular features that challenge the idea of homogeneous and indolent tumour subtypes.
Monday 17 May 2021
Monday Lunch Live with course convenors Professor Grant McArthur and Dr David Kok along with research supervisors.
Graduates present their work in rapid-fire presentations resulting in a comprehensive, multidisciplinary focus on cancer research and clinical care.
The diverse program covers topics including data-driven projects, the patient experience, registry data, translational, nursing and radiotherapy research.
Wednesday 21 April 2021
Breast Cancer Education Series with Professor Bruce Mann and Dr Belinda Yeo.
Imaging is critical in breast cancer management as it is central to early detection, assessing the spread of the disease and monitoring the response to therapy. In recent years there have been significant developments in the area including some that are controversial.
This webinar addresses some of these controversial aspects including the role of PET/CT in staging, assessing treatment response and the options for imaging in those having neoadjuvant systemic therapy. Participants also hear about the potential role of contrast enhanced mammography in the management of breast cancer, with opportunity for discussion.
Monday 19 April 2021
Monday Lunch Live with Dr Koen Degeling, Centre for Cancer Research and Centre for Health Policy of the University of Melbourne.
Simulation models are routinely used to estimate the health economic impact of drugs and medical devices, typically assessing whether their use is cost-effective and accessible.
Dr Degeling provides practical and methodological guidance essential to the adoption of patient-level simulation techniques within health economics and health services research. He explores the technology development and oncology care through several case studies including the use of simulation models to set priorities in the development of liquid and tissue-based biomarkers for risk stratification in prostate cancer, as well as their use to optimise treatment selection for metastatic colorectal cancer.
Wednesday 31 March 2021
Cancer and COVID-19 in Victoria with presenters Jeff Butcher, Dr Ben Teh, Prof Huyen Tran and Prof Ben Cowie.
With Phase 1B of the COVID-19 vaccine roll-out underway, the Victorian COVID-19 and Cancer Network (VCCN) convened an expert panel to present the latest information about the COVID-19 vaccine specifically for cancer clinicians.
Hear from a multidisciplinary panel of experts on key topics including latest COVID-19 vaccine safety and efficacy information and guidelines for vaccination for people with cancer, who have priority in Phase 1B of the roll out.
The program features a patient’s lived experience of a COVID-19 diagnosis during cancer treatment, and the challenges of being on active cancer treatment during the pandemic.
Wednesday 31 March 2021
Cancer and COVID-19 in Victoria moderated by A/Prof Sue-Anne McLachlan, VCCN Taskforce Chair and Director of Oncology and Cancer Services, St Vincent's Hospital, Melbourne,
An expert multidisciplinary panel discuss the latest COVID-19 vaccine safety and efficacy information, guidelines for vaccination for people with cancer and a patient’s lived experience of a COVID-19 diagnosis during cancer treatment, and the challenges of being on active cancer treatment during the pandemic.
Presenters: Prof Ben Cowie, Deputy Chief Health Officer, Department of Health, Dr Ben Teh, Infectious Diseases Physician, Peter MacCallum Cancer Centre, Prof Huyen Tran, Director of the Haemophilia Centre, Alfred Hospital, Dr Ines Rio, medical advisor and Chair, North Western Melbourne PHN and Donald Johnson, Nurse Unit Manager, Western Health COVID-19 Vaccine Hub.
Tuesday 30 March 2021
Head and Neck Cancer Symposium hosted by Professor David Wiesenfeld, VCCC Research & Education Lead for Head and Neck Cancer and Dr. Lachlan McDowell, Consultant Radiation Oncologist, Peter MacCallum Cancer Centre.
Multidisciplinary experts discuss the collective impact of a head and neck cancer diagnosis and how it may affect a patient's sense of self whilst addressing their sexual health post-survivorship.
Panel discussion with Professor Jane Hocking, Epidemiologist, University of Melbourne and Julie McCrossin AM, Consumer representative.
Monday 29 March 2021
Monday Lunch Live with Professor Mark Rosenthal, Peter MacCallum Cancer Centre, and Joseph Lukaitis, Chairman Picchi Brothers Foundation.
The 2020 winners of the Picchi Awards for Cancer Research present their award-winning research in the areas of population health, clinical and basic science, explaining their focus and future direction.
The awards, supported by the Picchi Brothers Foundation, are presented to PhD students who are undertaking cancer-related research training with a VCCC alliance member.
Wednesday 17 March 2021
Breast Cancer Education Series with Yael Marks, Peter MacCallum Cancer Centre and Dr Belinda Yeo, Austin Health.
This masterclass centres around on the contentious topic of de-escalating therapy. Hear from a panel of experts who will cover areas including:
Presentations followed by panel discussion.
Monday 1 March 2021
Monday Lunch Live with Mr David Wrede, Royal Women's Hospital and Professor Marion Saville AM, VCS Foundation Ltd. Hosted by Tamara Oudyn, ABC News.
As a result of its world-leading screening and vaccination programs, Australia is well on track to eliminate cervical cancer by 2035. Yet even here we can't be complacent. The COVID-19 pandemic impacted screening rates as women put off their regular health checks.
Experts Mr David Wrede and Professor Marion Saville AM navigate the opportunities and challenges of the World Health Organisation's call for the global elimination of cervical cancer by 2100.